Learn More
Medchemexpress LLC CWI1-2 | 2408590-36-1 | C22H17Cl3N6O3 | 5 MG

Supplier: Medchemexpress LLC HY1532745MG
CWI1-2 is an IGF2BP2 inhibitor that binds IGF2BP2 and inhibits its interaction with m6A-modified target transcripts. It induces apoptosis and differentiation, and demonstrates promising anti-leukemic effects.
- Binds to IGF2BP2
- Inhibits interaction with m6A-modified target transcripts
- Induces apoptosis and differentiation
- Shows promising anti-leukemic effects
- Exhibits antiproliferative activity with an IC50 of 200 nM against human THP-1 cells
- Reduces glutamine uptake and impairs mitochondrial function in AML cells
- Significantly inhibits the colony-forming ability of leukemic mouse blasts
- Greatly impairs the self-renewal of leukemic stem/initiating cells
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.